JD Health Announces Strong Mid-Year Growth

JD Health International, Inc. (HK:6618) has released an update.

JD Health International Inc. reports a robust first half of 2024, with revenues climbing to RMB 28.3 billion, marking a 4.6% increase from the previous year. The company, a leader in the ‘Internet + Healthcare’ sector, has also witnessed a significant rise in its user base to 181 million annual active accounts and averages over 480,000 online consultations daily. Additionally, JD Health has appointed Professor George Lau as an independent non-executive Director, underscoring its commitment to corporate governance and industry innovation.

For further insights into HK:6618 stock, check out TipRanks’ Stock Analysis page.